219 related articles for article (PubMed ID: 33731305)
21. Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective.
Alsumali A; Djatche LM; Briggs A; Liu R; Diakite I; Patel D; Wang Y; Lautsch D
Pharmacoeconomics; 2021 Nov; 39(11):1343-1354. PubMed ID: 34623625
[TBL] [Abstract][Full Text] [Related]
22. Cost-Effectiveness of Transitional Care Services After Hospitalization With Heart Failure.
Blum MR; Øien H; Carmichael HL; Heidenreich P; Owens DK; Goldhaber-Fiebert JD
Ann Intern Med; 2020 Feb; 172(4):248-257. PubMed ID: 31986526
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction.
Liang L; Bin-Chia Wu D; Aziz MIA; Wong R; Sim D; Leong KTG; Wei YQ; Tan D; Ng K
J Med Econ; 2018 Feb; 21(2):174-181. PubMed ID: 28959905
[TBL] [Abstract][Full Text] [Related]
24. Race Differences in Quality of Life following a Palliative Care Intervention in Patients with Advanced Heart Failure: Insights from the Palliative Care in Heart Failure Trial.
Tobin RS; Samsky MD; Kuchibhatla M; O'Connor CM; Fiuzat M; Warraich HJ; Anstrom KJ; Granger BB; Mark DB; Tulsky JA; Rogers JG; Mentz RJ; Johnson KS
J Palliat Med; 2022 Feb; 25(2):296-300. PubMed ID: 34851740
[No Abstract] [Full Text] [Related]
25. Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation.
Lau D; Sandhu RK; Andrade JG; Ezekowitz J; So H; Klarenbach S
J Am Heart Assoc; 2021 Jul; 10(14):e019599. PubMed ID: 34238020
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
[TBL] [Abstract][Full Text] [Related]
27. Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States.
Zueger PM; Kumar VM; Harrington RL; Rigoni GC; Atwood A; DiDomenico RJ; Touchette DR
Pharmacotherapy; 2018 May; 38(5):520-530. PubMed ID: 29601093
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness analysis of palbociclib or ribociclib in the treatment of advanced hormone receptor-positive, HER2-negative breast cancer.
Zhang B; Long EF
Breast Cancer Res Treat; 2019 Jun; 175(3):775-779. PubMed ID: 30847728
[TBL] [Abstract][Full Text] [Related]
29. Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis.
Jiang X; Yao J; You JH
JMIR Mhealth Uhealth; 2020 Jul; 8(7):e17846. PubMed ID: 32407288
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF.
McEwan P; Darlington O; McMurray JJV; Jhund PS; Docherty KF; Böhm M; Petrie MC; Bergenheim K; Qin L
Eur J Heart Fail; 2020 Nov; 22(11):2147-2156. PubMed ID: 32749733
[TBL] [Abstract][Full Text] [Related]
31. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
[TBL] [Abstract][Full Text] [Related]
32. The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective.
Cowie MR; Simon M; Klein L; Thokala P
Eur J Heart Fail; 2017 May; 19(5):661-669. PubMed ID: 28176424
[TBL] [Abstract][Full Text] [Related]
33. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of a Telemonitoring Program for Patients With Heart Failure During the COVID-19 Pandemic in Hong Kong: Model Development and Data Analysis.
Jiang X; Yao J; You JH
J Med Internet Res; 2021 Mar; 23(3):e26516. PubMed ID: 33656440
[TBL] [Abstract][Full Text] [Related]
35. Cooled radiofrequency ablation of the genicular nerves for chronic pain due to osteoarthritis of the knee: a cost-effectiveness analysis compared with intra-articular hyaluronan injections based on trial data.
Desai MJ; Bentley A; Keck WA
BMC Musculoskelet Disord; 2022 May; 23(1):491. PubMed ID: 35610642
[TBL] [Abstract][Full Text] [Related]
36. Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial.
Li J; Parrott S; Sweeting M; Farmer A; Ross J; Dack C; Pal K; Yardley L; Barnard M; Hudda M; Alkhaldi G; Murray E
J Med Internet Res; 2018 Jun; 20(6):e201. PubMed ID: 29884608
[TBL] [Abstract][Full Text] [Related]
37. Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction.
Chew DS; Loring Z; Anand J; Fudim M; Lowenstern A; Rymer JA; Weimer KED; Atwater BD; DeVore AD; Exner DV; Noseworthy PA; Yancy CW; Mark DB; Piccini JP
Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e007094. PubMed ID: 33280436
[TBL] [Abstract][Full Text] [Related]
38. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
[TBL] [Abstract][Full Text] [Related]
39. Improving the monitoring of chronic heart failure in Argentina: is the implantable pulmonary artery pressure with CardioMEMS Heart Failure System cost-effective?
Alcaraz A; Rojas-Roque C; Prina D; González JM; Pichon-Riviere A; Augustovski F; Palacios A
Cost Eff Resour Alloc; 2021 Jul; 19(1):40. PubMed ID: 34243782
[TBL] [Abstract][Full Text] [Related]
40. A cost-effectiveness study of person-centered integrated heart failure and palliative home care: Based on a randomized controlled trial.
Sahlen KG; Boman K; Brännström M
Palliat Med; 2016 Mar; 30(3):296-302. PubMed ID: 26603186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
